USANA Health Sciences Return on Tangible Equity 2010-2025 | USNA

Current and historical return on tangible equity values for USANA Health Sciences (USNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
USANA Health Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $0.04B $0.24B 10.22%
2024-09-30 $0.06B $0.49B 11.84%
2024-06-30 $0.06B $0.47B 12.26%
2024-03-31 $0.06B $0.45B 14.17%
2023-12-31 $0.06B $0.45B 14.81%
2023-09-30 $0.06B $0.42B 14.42%
2023-06-30 $0.06B $0.42B 16.00%
2023-03-31 $0.07B $0.41B 17.28%
2022-12-31 $0.07B $0.39B 19.15%
2022-09-30 $0.08B $0.36B 21.67%
2022-06-30 $0.09B $0.35B 25.29%
2022-03-31 $0.11B $0.34B 30.33%
2021-12-31 $0.12B $0.35B 32.58%
2021-09-30 $0.14B $0.35B 37.01%
2021-06-30 $0.14B $0.37B 38.33%
2021-03-31 $0.13B $0.36B 37.30%
2020-12-31 $0.13B $0.39B 38.44%
2020-09-30 $0.12B $0.34B 38.27%
2020-06-30 $0.11B $0.30B 38.29%
2020-03-31 $0.10B $0.27B 34.89%
2019-12-31 $0.10B $0.31B 31.97%
2019-09-30 $0.10B $0.27B 31.34%
2019-06-30 $0.11B $0.34B 30.68%
2019-03-31 $0.12B $0.34B 33.38%
2018-12-31 $0.13B $0.34B 34.64%
2018-09-30 $0.09B $0.39B 24.74%
2018-06-30 $0.08B $0.38B 24.05%
2018-03-31 $0.07B $0.35B 21.52%
2017-12-31 $0.06B $0.31B 19.73%
2017-09-30 $0.09B $0.31B 29.51%
2017-06-30 $0.10B $0.33B 33.02%
2017-03-31 $0.10B $0.30B 37.68%
2016-12-31 $0.10B $0.27B 42.69%
2016-09-30 $0.10B $0.25B 45.95%
2016-06-30 $0.10B $0.22B 44.04%
2016-03-31 $0.10B $0.19B 43.30%
2015-12-31 $0.10B $0.23B 42.18%
2015-09-30 $0.09B $0.26B 43.45%
2015-06-30 $0.09B $0.23B 46.51%
2015-03-31 $0.08B $0.19B 45.14%
2014-12-31 $0.08B $0.17B 41.82%
2014-09-30 $0.08B $0.14B 39.68%
2014-06-30 $0.07B $0.20B 36.78%
2014-03-31 $0.08B $0.22B 41.43%
2013-12-31 $0.08B $0.20B 47.88%
2013-09-30 $0.08B $0.18B 52.56%
2013-06-30 $0.08B $0.15B 56.51%
2013-03-31 $0.07B $0.13B 54.37%
2012-12-31 $0.07B $0.13B 50.97%
2012-09-30 $0.06B $0.14B 48.22%
2012-06-30 $0.06B $0.12B 47.86%
2012-03-31 $0.05B $0.13B 48.51%
2011-12-31 $0.05B $0.11B 50.00%
2011-09-30 $0.05B $0.10B 52.41%
2011-06-30 $0.05B $0.09B 57.64%
2011-03-31 $0.05B $0.09B 54.18%
2010-12-31 $0.05B $0.09B 55.09%
2010-09-30 $0.04B $0.07B 55.87%
2010-06-30 $0.04B $0.09B 52.00%
2010-03-31 $0.04B $0.08B 58.27%
2009-12-31 $0.03B $0.07B 65.38%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.529B $0.855B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $95.374B 35.78
Zoetis (ZTS) US $69.448B 26.29
Daiichi Sankyo, - (DSNKY) JP $48.414B 24.63
Takeda Pharmaceutical (TAK) JP $47.824B 10.59
Sandoz Group AG (SDZNY) CH $18.977B 0.00
Summit Therapeutics (SMMT) US $18.321B 0.00
Merck (MKKGY) DE $17.848B 14.77
Shionogi (SGIOY) JP $14.096B 14.12
United Therapeutics (UTHR) US $13.255B 11.73
Neurocrine Biosciences (NBIX) US $10.546B 32.40
IPSEN (IPSEY) FR $9.907B 0.00
Orion OYJ (ORINY) FI $9.027B 24.41
Corcept Therapeutics (CORT) US $7.580B 57.65
Madrigal Pharmaceuticals (MDGL) US $7.276B 0.00
Stevanato Group S.p.A (STVN) IT $6.281B 39.88
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.047B 0.00
Grifols, S.A (GRFS) ES $4.827B 0.00
Soleno Therapeutics (SLNO) US $3.744B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.138B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.960B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.399B 14.89
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.211B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.822B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.798B 0.00
Indivior (INDV) US $1.593B 6.75
Guardian Pharmacy Services (GRDN) US $1.568B 0.00
Evotec AG (EVO) DE $1.502B 0.00
ARS Pharmaceuticals (SPRY) US $1.391B 177.00
Dyne Therapeutics (DYN) US $1.362B 0.00
Ocular Therapeutix (OCUL) US $1.359B 0.00
Ardelyx (ARDX) US $1.304B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.121B 45.56
Enliven Therapeutics (ELVN) US $0.974B 0.00
Harrow (HROW) US $0.917B 0.00
Collegium Pharmaceutical (COLL) US $0.869B 4.62
Avadel Pharmaceuticals (AVDL) IE $0.832B 0.00
Xencor (XNCR) US $0.773B 0.00
Cronos Group (CRON) CA $0.721B 0.00
AleAnna (ANNA) US $0.718B 0.00
Xeris Biopharma Holdings (XERS) US $0.701B 0.00
KalVista Pharmaceuticals (KALV) US $0.676B 0.00
Organogenesis (ORGO) US $0.629B 0.00
Akebia Therapeutics (AKBA) US $0.626B 0.00
Bioventus (BVS) US $0.595B 15.45
Savara (SVRA) US $0.563B 0.00
Relay Therapeutics (RLAY) US $0.561B 0.00
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.520B 0.00
Verve Therapeutics (VERV) US $0.490B 0.00
Tourmaline Bio (TRML) US $0.458B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.458B 0.00
Elite Pharmaceuticals (ELTP) US $0.454B 0.00
Zevra Therapeutics (ZVRA) US $0.418B 0.00
Altimmune (ALT) US $0.398B 0.00
Siga Technologies (SIGA) US $0.388B 6.62
Oruka Therapeutics (ORKA) US $0.378B 0.00
CytoDyn (CYDY) US $0.368B 0.00
Heron Therapeutics (HRTX) US $0.358B 0.00
Rigel Pharmaceuticals (RIGL) US $0.334B 19.92
Aquestive Therapeutics (AQST) US $0.298B 0.00
ProKidney (PROK) US $0.250B 0.00
Avita Medical (RCEL) US $0.247B 0.00
Nature's Sunshine Products (NATR) US $0.227B 26.70
Wellgistics Health (WGRX) US $0.223B 0.00
OmniAb (OABI) US $0.216B 0.00
Esperion Therapeutics (ESPR) US $0.195B 24.60
MediWound (MDWD) IL $0.186B 0.00
Larimar Therapeutics (LRMR) US $0.183B 0.00
Korro Bio (KRRO) US $0.173B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Aldeyra Therapeutics (ALDX) US $0.162B 0.00
4D Molecular Therapeutics (FDMT) US $0.159B 0.00
Journey Medical (DERM) US $0.159B 0.00
Lexeo Therapeutics (LXEO) US $0.156B 0.00
Nanobiotix S.A (NBTX) FR $0.156B 0.00
Procaps Group, S.A (PROCF) LU $0.156B 0.00
Aclaris Therapeutics (ACRS) US $0.149B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.148B 45.60
Nektar Therapeutics (NKTR) US $0.145B 0.00
Profound Medical (PROF) CA $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.139B 0.00
Protara Therapeutics (TARA) US $0.133B 0.00
Enanta Pharmaceuticals (ENTA) US $0.129B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.116B 0.00
VAXART, INC (VXRT) US $0.098B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.092B 0.00
Champions Oncology (CSBR) US $0.088B 14.50
Achieve Life Sciences (ACHV) CA $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Galectin Therapeutics (GALT) US $0.082B 0.00
ESSA Pharma (EPIX) CA $0.079B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.075B 0.00
Dominari Holdings (DOMH) US $0.075B 0.00
Nutriband (NTRB) US $0.070B 0.00
Pyxis Oncology (PYXS) US $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.067B 0.00
Inotiv (NOTV) US $0.067B 0.00
Gain Therapeutics (GANX) US $0.064B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Fractyl Health (GUTS) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Karyopharm Therapeutics (KPTI) US $0.058B 0.00
Metagenomi (MGX) US $0.056B 0.00
ElectroCore (ECOR) US $0.054B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.048B 0.00
Mural Oncology (MURA) IE $0.045B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
Prelude Therapeutics (PRLD) US $0.040B 0.00
Rafael Holdings (RFL) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
SCYNEXIS (SCYX) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.036B 0.00
Surrozen (SRZN) US $0.034B 0.00
FibroGen (FGEN) US $0.034B 0.00
PolyPid (PYPD) IL $0.029B 0.00
Tempest Therapeutics (TPST) US $0.025B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.020B 0.00
Mannatech (MTEX) US $0.020B 7.86
Lipocine (LPCN) US $0.019B 0.00
Natural Alternatives (NAII) US $0.019B 0.00
DURECT (DRRX) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
BioVie (BIVI) US $0.016B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
TransCode Therapeutics (RNAZ) US $0.013B 0.00
Cosmos Health (COSM) US $0.013B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.79
Relmada Therapeutics (RLMD) US $0.012B 0.00
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.16
Biomerica (BMRA) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Carisma Therapeutics (CARM) US $0.008B 0.00
Ainos (AIMD) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Mangoceuticals (MGRX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Jaguar Animal Health (JAGX) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Citius Pharmaceuticals (CTXR) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00